About the Event

Cell and gene therapies are revolutionising healthcare and delivering outstanding outcomes for patients. The pipeline of products is growing, providing potential cures for previously intractable conditions and creating new business models for healthcare innovation companies.

The challenges in the production and manufacturing of these new therapies is a recognised bottleneck. Transformation of supply chains and the development of new therapeutic delivery systems will be required to embrace the economic and health opportunities that cell and gene therapies provide.

---